Wealth Enhancement Advisory Services’s Viemed Healthcare VMD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$135K	Buy	+11,007	New	+$109K	﹤0.01%	3724

Other funds holding VMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Wealth Enhancement Advisory Services's VMD Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Viemed Healthcare (VMD) in Q2 2026: 11,007 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #3724 among its holdings.

166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

Wealth Enhancement Advisory Services held 11,007 shares of Viemed Healthcare worth $135K as of Q2 2026.
Viemed Healthcare was a new Wealth Enhancement Advisory Services position in Q2 2026.
Viemed Healthcare made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3724 holding.
166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.